Source: Thrombosis Research. Unidades: FORP, FCFRP, FMRP
Subjects: ANTICOAGULANTES, OSTEOCLASTO, OSTEOBLASTO, CULTURA DE CÉLULAS
ABNT
ROCHA, Amanda Leal et al. Inhibitory effects of dabigatran etexilate, a direct thrombin inhibitor, on osteoclasts and osteoblasts. Thrombosis Research, v. 186, p. 45-53, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.thromres.2019.12.014. Acesso em: 17 ago. 2024.APA
Rocha, A. L., Bighetti-Trevisan, R. L., Duffles, L. F., Arruda, J. A. A. de, Taira, T. M., Assis, B. R. D., et al. (2020). Inhibitory effects of dabigatran etexilate, a direct thrombin inhibitor, on osteoclasts and osteoblasts. Thrombosis Research, 186, 45-53. doi:10.1016/j.thromres.2019.12.014NLM
Rocha AL, Bighetti-Trevisan RL, Duffles LF, Arruda JAA de, Taira TM, Assis BRD, Macari S, Diniz IMA, Beloti MM, Rosa AL, Fukada SY, Goulart GAC, Ribeiro DD, Abreu LG, Silva TA. Inhibitory effects of dabigatran etexilate, a direct thrombin inhibitor, on osteoclasts and osteoblasts [Internet]. Thrombosis Research. 2020 ; 186 45-53.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1016/j.thromres.2019.12.014Vancouver
Rocha AL, Bighetti-Trevisan RL, Duffles LF, Arruda JAA de, Taira TM, Assis BRD, Macari S, Diniz IMA, Beloti MM, Rosa AL, Fukada SY, Goulart GAC, Ribeiro DD, Abreu LG, Silva TA. Inhibitory effects of dabigatran etexilate, a direct thrombin inhibitor, on osteoclasts and osteoblasts [Internet]. Thrombosis Research. 2020 ; 186 45-53.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1016/j.thromres.2019.12.014